tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Hoth Therapeutics granted Japanese patent for HT-KIT platform

Hoth Therapeutics (HOTH) has been granted a patent for the HT-KIT platform by the Japan Patent Office on May 7, with exclusive protection until August 27, 2039. The granted patent protects Hoth’s approach of using splice-switching oligonucleotides to selectively disrupt KIT gene expression in mast cells-cells implicated in conditions ranging from chronic hives to rare cancers. HT-KIT is one of several novel platforms under development at Hoth Therapeutics.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1